Common adverse reactions: nausea, upper respiratory tract infection, urinary tract infection, and dizziness.
Adverse reactions occurring in clinical studies include urinary tract infections, upper respiratory tract infections, herpes zoster, pneumonia, neutropenia, hypercholesterolemia, dizziness, nausea, and elevated creatine kinase levels.
from FDA,2023.07